Direct Neuronal Reprogramming: Bridging the Gap Between Basic Science and Clinical Application.

Area of Science:

• Neuroscience
• Stem Cell Biology
• Regenerative Medicine

Background:

• Direct neuronal reprogramming converts somatic cells into induced neurons (iNs) without a pluripotent state, offering a novel approach to neuroregeneration.
• This technology holds promise for treating neurodegenerative diseases and brain injuries characterized by neuronal loss, where endogenous neurogenesis is limited.
• Understanding intrinsic cues (transcription factors, miRNAs) and extrinsic cues (growth factors, small molecules) from embryonic development has been crucial for advancing reprogramming strategies.

Purpose of the Study:

• To provide a comprehensive overview of direct neuronal reprogramming.
• To highlight key historical developments and recent accomplishments in the field.
• To discuss the therapeutic potential of direct neuronal reprogramming for neurological disorders.

Main Methods:

• Reviewing literature on direct neuronal reprogramming methodologies over the past two decades.
• Summarizing the use of transcription factors, miRNAs, growth factors, and small molecules in inducing neurogenesis.
• Discussing in situ neuronal lineage conversion strategies targeting glial cells.

Main Results:

• Direct neuronal reprogramming has demonstrated the capacity to generate induced neurons from various somatic cell types.
• Reprogramming strategies have evolved, incorporating both genetic and small molecule approaches.
• In situ reprogramming of resident glial cells has emerged as a promising clinical application.

Conclusions:

• Direct neuronal reprogramming represents a significant advancement in neuroscience with substantial therapeutic potential.
• The technology offers a viable strategy for cell replacement therapy in conditions involving neuronal loss.
• Continued research into reprogramming mechanisms and clinical applications is essential for realizing its full potential.